Literature DB >> 29511988

A Descriptive Analysis of a Community Clinic Providing Hepatitis C Treatment to Poor and Uninsured Patients.

Omar T Sims1,2,3,4, Pamela A Melton5, Shaonin Ji6.   

Abstract

This study describes clinical characteristics of poor and uninsured patients living with hepatitis C virus (HCV) who received care from a multidisciplinary HCV clinic, reports treatment completion and cure rates, and estimates the cost of HCV medications provided at no cost to uninsured patients. A retrospective chart review was performed and identified 69 uninsured HCV patients who received medical care at Mercy Health Center, a small non-profit community clinic, between January 2008 and March 2015. Three-fourths of the patients were unemployed, a third had multiple HCV exposures, nearly half acquired HCV due to illicit drug use, and more than half had active psychiatric disorders. Of those who received HCV treatment, 81% completed treatment and 85% were achieved virological cure. The multidisciplinary community clinic provided > $1.4 million of HCV antivirals at no cost to uninsured patients. Findings suggest a multidisciplinary community clinic comprised of a social worker, pharmacist, gastroenterologist, nurse, nurse practitioner, psychologist, and dietitian can help patients achieve HCV treatment completion and cure rates comparable to traditional physician-led clinics, and successfully manage uninsured and underserved HCV patients-who are often regarded as "difficult-to-treat" patients. Public health social workers and other health professionals are encouraged to advocate for treatment and care of poor and uninsured patients living with HCV in health agencies and health systems, otherwise population-wide reductions in HCV morbidity and mortality will not be realized.

Entities:  

Keywords:  Community clinic; Hepatitis C; Poor and uninsured patients; Treatment

Mesh:

Substances:

Year:  2018        PMID: 29511988     DOI: 10.1007/s10900-018-0476-2

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  22 in total

1.  A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

Authors:  Lisa I Backus; Derek B Boothroyd; Barbara R Phillips; Pamela Belperio; James Halloran; Larry A Mole
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-11       Impact factor: 11.382

2.  Is the US AIDS drug assistance program cost-effective?

Authors:  Steven D Pinkerton; Jennifer Kibicho; Carol L Galletly
Journal:  AIDS Behav       Date:  2013-01

Review 3.  Hepatitis C virus infection in USA: an estimate of true prevalence.

Authors:  Eric Chak; Andrew H Talal; Kenneth E Sherman; Eugene R Schiff; Sammy Saab
Journal:  Liver Int       Date:  2011-03-16       Impact factor: 5.828

4.  Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States.

Authors:  Maria Stepanova; Fasiha Kanwal; Hashem B El-Serag; Zobair M Younossi
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

5.  Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010.

Authors:  Reena Mahajan; Jian Xing; Stephen J Liu; Kathleen N Ly; Anne C Moorman; Loralee Rupp; Fujie Xu; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-02-12       Impact factor: 9.079

6.  Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; John W Ward
Journal:  Ann Intern Med       Date:  2012-12-04       Impact factor: 25.391

Review 7.  Behavioral Interventions to Reduce Alcohol Use Among Patients with Hepatitis C: A Systematic Review.

Authors:  Omar T Sims; Quentin R Maynard; Pam A Melton
Journal:  Soc Work Public Health       Date:  2016-06-13

Review 8.  Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review.

Authors:  Alan Hoi Lun Yau; Eric M Yoshida
Journal:  Can J Gastroenterol Hepatol       Date:  2014-09

9.  Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature review.

Authors:  Amirhossein Modabbernia; Hossein Poustchi; Reza Malekzadeh
Journal:  Hepat Mon       Date:  2013-01-07       Impact factor: 0.660

Review 10.  New era for management of chronic hepatitis C virus using direct antiviral agents: A review.

Authors:  Tamer Elbaz; Mohamed El-Kassas; Gamal Esmat
Journal:  J Adv Res       Date:  2014-11-27       Impact factor: 10.479

View more
  4 in total

Review 1.  Hepatitis C models of care: approaches to elimination.

Authors:  Mia J Biondi; Jordan J Feld
Journal:  Can Liver J       Date:  2020-06-04

2.  A Cross-Sectional Analysis of Tobacco Use and Concurrent Alcohol and Substance Use Among Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center.

Authors:  Omar T Sims; Asti Jackson; Yuqi Guo; Duong N Truong; Emmanuel A Odame; Hadii M Mamudu
Journal:  J Clin Psychol Med Settings       Date:  2020-10-01

Review 3.  Building a Hepatitis C Clinical Program: Strategies to Optimize Outcomes.

Authors:  Autumn Zuckerman; Alicia Carver; Cody A Chastain
Journal:  Curr Treat Options Infect Dis       Date:  2018-10-18

4.  Time to HCV Treatment Disfavors Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center.

Authors:  Omar T Sims; Duong N Truong; Kaiying Wang; Pamela A Melton; Kasey Atim
Journal:  J Racial Ethn Health Disparities       Date:  2021-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.